Spend 60 minutes with experts Julien de Salaberry (CEO, Galen Growth) and Dr. Sara Schmachtenberg (Head of Data Analytics, Galen Growth), as they explore how innovations in digital healthcare and biopharma are transforming the delivery of care. Throughout the conversation, you'll hear why rewriting healthcare is an important strategic imperative for all stakeholders.
Members who attend this session will learn about:
The funding challenges some digital health ventures have encountered, and the ventures that have accelerated in growth
The importance of scrutinizing clinical evidence in today's healthcare sector
The factors that will contribute to a digital health transformation in the coming months